NIH Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence

Inflammasome Lab's Kate Schroder is delighted to join the International Council of Affiliate Members of the Autophagy, Inflammation, and Metabolism Center of Biomedical Research Excellence (the AIM Center), located in New Mexico, USA.

 

The AIM Center is a locally, nationally, and internationally important centre for the advancement of research on autophagy and its intersections with inflammation and metabolism in the disease process. The AIM Center is funded by an NIH grant, and it endows the state of New Mexico and the surrounding region with a state-of-the-art biomedical centre and an intellectual and technological hub for cutting-edge research. On a larger scale, the AIM Center promises to be a nationally important centre for the advancement of research on autophagy, affording the nation a resource for the development of innovative approaches in treating a wide spectrum of diseases. Furthermore, given its support of exceptional junior and senior investigators through multi-year projects and pilots, the potential depth of its scientific output and its impact on the treatment of a multitude of diseases will grow this centre into one of international significance.

 

The AIM Center is directed by Prof Vojo Deretic of the University of New Mexico Health Sciences Center, and incorporates autophagy, inflammation and metabolism researchers across the globe.

 

Read more about The AIM Center and its goals on the AIM Center Website or on Pubmed

 

Posted by admin

ABOUT Inflammasome Lab

Inflammasome Lab is a group of researchers led by Dr Kate Schroder at the Institute for Molecular Bioscience, The University of Queensland.
We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to allow for new therapies to fight human diseases.